Chip most recently served as President and Chief Executive Officer of Genocea Biosciences, Inc. Prior to joining Genocea, he served as Chief Business Officer at Vanda Pharmaceuticals (NASDAQ: VNDA), a biopharmaceutical company he co-founded in 2004. Prior to Vanda, Chip was a principal at Care Capital, a venture capital firm investing in biopharmaceutical companies, after serving in a variety of commercial and strategic roles at SmithKline Beecham (now GlaxoSmithKline). Chip holds a B.A. from Harvard University and an M.B.A. from The Wharton School at the University of Pennsylvania.